Boosters can wane, 4th Covid shot may be necessary: Moderna CEO

In the wake of Omicron spreading rapidly around the globe, Israel has rolled out a fourth dose for over-60s, while health authorities in Germany, UK and France are planning a second booster

Covid-19 vaccines, Coronavirus vaccines, Vaccination
IANS Washington
2 min read Last Updated : Jan 07 2022 | 5:02 PM IST

The efficacy of boosters against Covid-19 will likely decline over time, and people may need a fourth shot to increase their protection, Moderna CEO Stephane Bancel has said.

According to Bancel, people who received their boosters last year will likely have enough protection to get them through the winter, when new infections surge as people gather indoors to escape the cold.

However, he said that the efficacy of boosters will probably decline over the course of several months, similar to what happened with the first two doses, CNBC reported on Thursday.

"I will be surprised when we get that data in the coming weeks that it's holding nicely over time - I would expect that it's not going to hold great," Bancel was quoted as saying, referring to the strength of the booster shots.

However, Oxford vaccine expert Sir Andrew Pollard recently said that regular booster doses every four-six to fight Covid may not be a sustainable way to prevent Covid infections.

"Administering booster vaccines to everyone every six months was 'not sustainable'," Pollard was quoted as saying to the Daily Mail.

"We can't vaccinate the planet every four-six months. It's not sustainable or affordable. In the future, we need to target the vulnerable," said Pollard, who was chief investigator of the Oxford Covid vaccine trials and director of the Oxford Vaccine Group, which developed AstraZeneca's jab.

"Today, less than 10 per cent of people in low income families have even had their first dose, so the whole idea of fourth doses globally is just not sensible," Pollard was quoted as saying to Sky News.

According to Pollard, future immunisation drives should target the most vulnerable, rather than all adults.

In the wake of Omicron spreading rapidly around the globe, Israel has rolled out a fourth dose for over-60s, while health authorities in Germany, UK and France are planning a second booster.

--IANS

rvt/vd

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

First Published: Jan 07 2022 | 5:02 PM IST

Next Story